Report Description Table of Contents Introduction: - In 2020, the Point of Care or Rapid Diagnostics Market share was USD 29.638billion. It is predicted to reach USD 70.231 billion by 2028, representing a CAGR of 11.78 percent throughout the forecasted period of 2020-2028. Point of Care Diagnostics (POC) is an integral part of clinical diagnostics that helps assesschronic diseases and acute infections. In the United States, 7 out of 10 people die due to chronic diseases each year. Chronic diseases cause more than 38 million deaths each year around the world, with cardiovascular diseases resulting in the primary cause of fatalities (approximately 17.5 million people each year) followed by Cancer (8.2 million), diseases related to the respiratory systems (4 million), and diabetes (1.5 million). Acute infections involve influenza, pneumonia, respiratory tract infection, etc. Acute respiratory infection (ARI) is one of the major causes of fatalities in children. It is estimated that approximately every year around (11 to 22) % of deaths among children less than five years and 3% of deaths among adults between (15 to 49) years of age occur globally due to ARI. The above statistics are going to have a positive impact on the growth rate of the point of care diagnostics market during the projected period of 2020-2028 POC provides ample opportunities for the community pharmacies to increase their revenue by expanding patient care services all across the world. POCT devicesare the instruments that are implemented for acquiring clinical information about patients worldwide. The POCT devices contribute nearly (7-8) % of the entire medical devices market.Moreover, these devices created a significant impact on the whole microbiological culture. The applications of POCTs for microbiology can be used as a surveillance tool to identify pathogens like the influenza virus and Zika virus. The Point of Care Faecal Immunochemical Testing (POCFIT) is widely used to detect the Haemoglobin content in the faeces andis also used as a screening tool to detect Colorectal Cancer (CRC). Faecal Matter occurs due to the absorption of insufficient fluid by the colon. COVID-19 Impact onPoint of Care/ Rapid Diagnostics Market: - The sudden COVID-19 outbreak had a positive impact on the POC market. It has increased the demand for diagnostic kits for the rapid detection of chronic diseases and acute infections. With the rapid increase in the need for prompt diagnostic results due to the COVID-19 pandemic, the demand for POC drastically rose all around the world. Moreover, the rising prevalence of COVID-19 cases all across the globe has compelled the governments to invest more towards patient management, which has immensely boosted the demand for rapid antigen tests. Such a rapidly detecting tool is very much crucial for providing accurate treatment options to the patients. The ELISA test was also introduced to check whether an individual has antibodies in their blood against the SARS-CoV-2 virus. Furthermore, the point of care rapid diagnostics testsis conducted to detect current or past SARS-CoV-2 virus infections adequately. Point-Of-Care Diagnostics Market Trends and Growth Drivers Market Dynamics: - Market Drivers: - An uprise in the prevalence of infectious diseases worldwide is one of the significant causes that is fuelling the overall market growth. According to WHO, more than 17 million people across the world die each year due to infectious diseases, thereby leading to the robust growth of the POC Diagnostics Market. Lab-on-a-chip technology is also one of the pivotal drivers of POC testing that enables the different bioassays like PCR and ELISA tests to be conducted at the POC centers, driving the market at a good pace. Usage of saliva as a liquid biopsy, rise in need of POC testing in clinical microbiology,and an increase in investments by the leading market players on the point of care diagnostics are some of the vital causes driving the overall growth rateof the market. Also, the rising prevalence of severalPOC testingprocesses like Neuropsychological tests, urine analysis, pregnancy tests, testing for Chlamydia, cholesterol levels, international normalized ratio tests, Haemoglobin A1c tests, blood alcohol content, cardiac biomarkers, D-dimer, ionized calcium levels, arterial blood test gas analysis, electrolyte test, lactate blood test, point of care coagulation testing, Multiplexed point-of-care testing, etc. are propelling the overall market growth to a great extent. Restraints: - The implication of stringent regulatory policies by the FDA is a significant barrier that can restrain the overall market growth. POC Diagnostics Market Opportunities and Technology Trends Decentralization of healthcare centers all across the globe has highly increased the efficacy rate of the market and is likely to make substantial growth in the future. US healthcare systems have already implemented this technique, while many European countries widely focuson decentralizing their healthcare systems. Also, the usage of IVD point-of-care test devices is increasing rapidly. Therefore, it is highly estimated to improve the UK Global Point-of-Care Diagnostics Market outlook in the future. Point Of Care Diagnostics Market Analysis The Point of Care/ Rapid Diagnostics Marketis broadly segmented based on Product, Mode of Purchase, Platform, End-User, And Regions. Based on Product Glucose Monitoring Products Infectious Disease Testing Products Coagulation Monitoring Products Fecal Occult Testing Products Cardiometabolic Monitoring Products Pregnancy & Fertility Testing Products Cholesterol Testing Products Cancer Marker Testing Products Urinalysis Testing Products Hematology Testing Products Drugs-of-abuse Testing Products Other POC Products Based On Mode of Purchase OTC Testing Products Prescription-based Testing Products Based On Platform Lateral Flow Assays Immunoassays Microfluidics Molecular Diagnostics Dipsticks Based On End-User Hospitals and Critical Care Centers Home Care Outpatient and Ambulatory Care Facilities Others Based on Regions North America US Canada Mexico Rest of North America Europe Russia Switzerland U.K Finland Spain France Turkey Netherlands Germany Belgium Italy Rest of Europe Asia Pacific India China Malaysia South Korea Australia Thailand Japan Indonesia New Zealand Philippines Singapore Rest of Asia-Pacific LAMEA Uruguay Brazil Saudi Arabia Argentina Rest of LAMEA Based on Product: Glucose Monitoring Products dominated the market in 2020 with a CAGR of 7.73%,and a market share of USD 12.73 billion, due to the increase in demand for home glucose testing, a continuous rise in the number of patients, and adoption of highly upgraded technologies among the researchers worldwide. Based on Mode of Purchase: OTC Testing Products has the largest market share with an overall CAGR of 11.63%. The demand for early detection of diseases and growing awareness of the usage of POC products are driving the growth of this segment significantly. Based on Platform: Lateral Flow Assays dominated the market comprehensivelyin 2020, with a CAGR of 4.93% and an overall share of 8.273 billiondue to the increase inLFA-based POC devices and a rise in awareness of POC testing advantages. Based on End-User: Hospitals and Critical Care Centres accounted for the largest market share due to the rise in demand for cost-effective and highly efficient POC diagnostics products, rising prevalence of long-term care, and frequent monitoring of chronic illness and acute infections. According to the AHA (American Hospital Association), at present, there are a total of 6090 hospitals in the United States out of which there are 2946 Nongovernment Not-for-Profit Community Hospitals, 962 Local and State Government Community Hospitals, 1233 Investor-Owned (For-Profit) Community Hospitals, 625 Non-Federal Psychiatric Hospitals, 208 Federal Government Hospitals, and 116 other types of hospitals. Regional Analysis: North America dominated the POC diagnostics market with an overall CAGR of 9.83%,because of highly favorable government policies, high awareness of self-testing, etc. In 2020, the US point of care diagnostics market sizeaccounted for up to USD 5.83 billion. The European Point of Care Diagnostic Marketis estimated to be the second-largest market after North America. UK, France, and Germany are the three most dominant countries in the European POC diagnostics market. On the other hand, Asia Pacific is the fastest-growing regionof the POC diagnostics market. ThePoint of Care Diagnostics Market in India resulted in high growth potential for the organizations involved in the development and distribution of point of care devices. Moreover, the POC Diagnostics Market in the Asia Pacific regionis growing comprehensively with a steady CAGR and is expected to reach up to USD 7.98 billion by 2028. Point of Care/ Rapid Diagnostics Market: Competitive Landscape The competitive landscape is the best tool for identifying the key competitors existing in the market environment worldwide. The comparison is made based on the total cost involved in R&D, global presence, market initiatives, market capability, company overview and financials, revenue generation, production facilities and sites, production capacity, organization flaws, and strengths, etc. The major players that are covered in thePoint of Care/ Rapid Diagnostics Market report are: Roche Diagnostics Siemens Healthineers Abbott Laboratories Danaher Corporation Becton Dickinson and Company Chembio Diagnostics Quidel Diagnostics EKF Diagnostics Trinity Biotech Fluxergy Point of Care/ Rapid Diagnostics Market: Recent Developments: - On Oct 15th, 2021, the United States FDA approved Roche’s Tecentriqwas introduced as adjuvant therapy for people suffering from early stages of lung cancer. Tecentriq is the only existing cancer immunotherapy that is available for adjuvant treatment of NSCLC. OnMar 27th, 2020, Abbott launched the Molecular Point-Of-Care test foraccurate detection of the Novel Coronavirus that workswithin five minutes. This test will continue to run on Abbot’s ID NOW platform, thus providing quick results in several healthcare facilities such as urgent care clinics, physician’s offices, and hospital emergency departments. The critical POC devices that market leaders develop Name of the product Function Key Players DCA Vantage Analyzer Chronic disease management Siemens Healthineers AFINION 2 Near Patient Testing at Point of Care Abbott Laboratories DPP SARS-CoV-2 Antigen Detection of nucleocapsid protein antigen to SARS-CoV-2 Chembio Diagnostics Frequently Asked Question About This Report 1) How big is the dollar value of the Point of Care/ Rapid Diagnostics Market? The Point of Care Diagnostics Market Sharewas USD 29.638 billion in 2020. It is predicted to reach USD 70.231 billion by 2028, with a CAGR of 11.78 percent throughout the forecasted period of 2020-2028. 2) Which market segment accounted for the largest Point of Care/ Rapid Diagnostics Market share based on the product? Based on Product, the ‘Glucose Monitoring Products’ segment accounted for the largest Point of Care/ Rapid Diagnostics Market share. 3) Who are the major players in the Point of Care/ Rapid Diagnostics Market? The key players in the Point of Care/ Rapid Diagnostics Market are Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Chembio Diagnostics, QuidelDiagnostics, EKF Diagnostics, Trinity Biotech, and Fluxergy. 4) What are the factors driving the Global Point of CareDiagnostics Market? Increase in prevalence of infectious diseases, technological advancements in the POC devices, and increase in investments by the leading market players are the factors that are driving the Point of Care/ Rapid Diagnostics Market. 5) Which End-User segment in the POC diagnostics market held the largest revenue share in 2020? Among the End-User segment, ‘Hospitals and Critical Care Centres’ in the POC diagnostics market held the largest revenue share in 2020. na Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Point of Care/ Rapid Diagnostics Market Segmentation 1.3.2 Geographic Scope Figure 02: Point of Care/ Rapid Diagnostics Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Point of Care/ Rapid Diagnostics Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Point of Care/ Rapid Diagnostics Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Point of Care/ Rapid Diagnostics Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Point of Care/ Rapid Diagnostics Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Point of Care/ Rapid Diagnostics Market, 2020–2028 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Point of Care/ Rapid Diagnostics Market, 2020–2028 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Point of Care/ Rapid Diagnostics Market, 2020–2028(USD Million) 3.1.4 Market Summary Figure 10: Glucose Monitoring Products to Witness Highest CAGR in Point of Care/ Rapid Diagnostics Market, By Product, During Forecast Period Figure 11: Hospitals and Critical Care Centres to Witness Higher CAGR in Point of Care/ Rapid Diagnostics Market for End-User Segment during Forecast Period Figure 12: OTC Testing Products to Witness Higher CAGR in Point of Care/ Rapid Diagnostics Market for Mode of Purchase Segment during Forecast Period Figure 13: Lateral Flow Assays to Witness Higher CAGR in Point of Care/ Rapid Diagnostics Market for Platform Segment during Forecast Period Figure 14: North America to Account for Largest Share of Global Point of Care/ Rapid Diagnostics Market In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 15: Point of Care/ Rapid Diagnostics Market Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Point of Care/ Rapid Diagnostics Market 5.2.1 Global Point of Care/ Rapid Diagnostics market, 2020 – 2028 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global Point of Care/ Rapid Diagnostics market, by region, 2020 - 2028 (USD Million) 5.4 Product Segment Analysis 5.4.1 Global Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 5.5 End-User Segment Analysis 5.5.1 Global Point of Care/ Rapid Diagnostics market, By End-User, 2020 - 2028 (USD Million) 5.6 Value Chain Analysis 5.7 Market Variable Analysis 5.7.1 Market Drivers Analysis 5.7.2 Market Restraints Analysis 5.8 Business Environment Analysis Tool 5.8.1 Point of Care/ Rapid Diagnostics market PEST analysis 5.8.2 Point of Care/ Rapid Diagnostics market Porter’s analysis 5.9 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 16 Point of Care/ Rapid Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 17 Point of Care/ Rapid Diagnostics Market Drivers and Their Impact 6.2.2 Restraints Figure 18 Point of Care/ Rapid Diagnostics Market Restraints and Their Impact 6.2.3 Opportunities Figure 19 Point of Care/ Rapid Diagnostics Market Opportunities and Their Impact 6.2.4 Challenges Figure 20 Point of Care/ Rapid Diagnostics Market Challenges and Their Impact 6.3 Impact of Covid-19 on Point of Care/ Rapid Diagnostics Market 6.4 Value Chain Analysis Figure 21 Value Chain Analysis: Point of Care/ Rapid Diagnostics Market 6.5 Ecosystem Figure 22 Point of Care/ Rapid Diagnostics Market: Ecosystem Table 3 Point of Care/ Rapid Diagnostics Market: Ecosystem Figure 23 Revenue Shift in Point of Care/ Rapid Diagnostics Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Point of Care/ Rapid Diagnostics Market in USA in Last 9 Years Figure 24 Top 10 Companies with Highest No. of Patents in Last 9 Years Figure 25 No of Patents Granted Per Year, 2019–2020 Table 5 List of Global Patents in Point of Care/ Rapid Diagnostics Market 6.7 Trade Analysis 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 6: Point of Care/ Rapid Diagnostics Market: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Mode of Purchase Analysis 6.11.1 Trends in Mode of Purchase (2014-2020) 6.11.2 Trends in Mode of Purchase (2021-2028) Table 7 Key Regulations: Point of Care/ Rapid Diagnostics Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 8: Key Players market share Figure 26: Key players market share of companies 7.2 Manufacturers Point of Care/ Rapid Diagnostics Manufacturing Sites, Area Served, Product Product 7.3 Point of Care/ Rapid Diagnostics Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Point of Care/ Rapid Diagnostics Market: Product Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2020-2028) Table 9 Point of Care/ Rapid Diagnostics Market, By Product, 2021–2028 (USD Million) Figure 27 Point of Care/ Rapid Diagnostics Market, By Product Figure 28 Glucose Monitoring Products Segment to Register Highest CAGR in Point of Care/ Rapid Diagnostics Market During Forecast Period 8.3 Glucose Monitoring Products 8.3.1 Glucose Monitoring Products market, 2020 - 2028 (USD Million) Figure 29: Glucose Monitoring Products market, 2020 - 2028 (USD Million) 8.4 Infectious Disease Testing Products 8.4.1 Infectious Disease Testing Products market, 2020 - 2028 (USD Million) Figure 30: Infectious Disease Testing Products market, 2020 - 2028 (USD Million) 8.5 Coagulation Monitoring Products 8.5.1 Coagulation Monitoring Products market, 2020 - 2028 (USD Million) Figure 31: Coagulation Monitoring Products market, 2020 - 2028 (USD Million) 8.6 Fecal Occult Testing Products 8.6.1 Fecal Occult Testing Products market, 2020 - 2028 (USD Million) Figure 32: Fecal Occult Testing Products market, 2020 - 2028 (USD Million) 8.7 Cardiometabolic Monitoring Products 8.7.1 Cardiometabolic Monitoring Products market, 2020 - 2028 (USD Million) Figure 33: Cardiometabolic Monitoring Products market, 2020 - 2028 (USD Million) 8.8 Pregnancy & Fertility Testing Products 8.8.1 Pregnancy & Fertility Testing Products market, 2020 - 2028 (USD Million) Figure 34: Pregnancy & Fertility Testing Products market, 2020 - 2028 (USD Million) 8.9 Cholesterol Testing Products 8.9.1 Cholesterol Testing Products market, 2020 - 2028 (USD Million) Figure 35: Cholesterol Testing Products market, 2020 - 2028 (USD Million) 8.10 Cancer Marker Testing Products 8.10.1 Cancer Marker Testing Products market, 2020 - 2028 (USD Million) Figure 36: Cancer Marker Testing Products market, 2020 - 2028 (USD Million) 8.11 Urinalysis Testing Products 8.11.1 Urinalysis Testing Products market, 2020 - 2028 (USD Million) Figure 37: Urinalysis Testing Products market, 2020 - 2028 (USD Million) 8.12 Hematology Testing Products 8.12.1 Hematology Testing Products market, 2020 - 2028 (USD Million) Figure 38: Hematology Testing Products market, 2020 - 2028 (USD Million) 8.13 Drugs-of-abuse Testing Products 8.13.1 Drugs-of-abuse Testing Products market, 2020 - 2028 (USD Million) Figure 39: Drugs-of-abuse Testing Products market, 2020 - 2028 (USD Million) 8.14 Other POC Products 8.14.1 Other POC Products market, 2020 - 2028 (USD Million) Figure 40: Other POC Products market, 2020 - 2028 (USD Million) Chapter 9. Global Point of Care/ Rapid Diagnostics Market: End-User Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2020-2028) Table 10: Point of Care/ Rapid Diagnostics Market, By End-User, 2021–2028 (USD Million) Figure 41: Point of Care/ Rapid Diagnostics Market, By End-User, 2021–2028 (USD Million) Figure 42: Hospitals and Critical Care Centers Segment to Register Highest CAGR in Point of Care/ Rapid Diagnostics Market during Forecast Period 9.3 Hospitals and Critical Care Centers 9.3.1 Hospitals and Critical Care Centers market, 2020 - 2028 (USD Million) Figure 43: Hospitals and Critical Care Centers market, 2020 - 2028 (USD Million) 9.4 Home Care 9.4.1 Home Care market, 2020 - 2028 (USD Million) Figure 44: Home Care market, 2020 - 2028 (USD Million) 9.5 Outpatient and Ambulatory Care Facilities 9.5.1 Outpatient and Ambulatory Care Facilities market, 2020 - 2028 (USD Million) Figure 45: Outpatient and Ambulatory Care Facilities market, 2020 - 2028 (USD Million) 9.6 Others 9.6.1 Others market, 2020 - 2028 (USD Million) Figure 46: Others market, 2020 - 2028 (USD Million) Chapter 10. Global Point of Care/ Rapid Diagnostics Market: Mode of Purchase Segment Analysis 10.1 Introduction 10.2 Sales Volume & Revenue Analysis (2020-2028) Table 11 Point of Care/ Rapid Diagnostics Market, By Mode of Purchase, 2021–2028 (USD Million) Figure 47 Point of Care/ Rapid Diagnostics Market, By Mode of Purchase Figure 48 OTC Testing Products Segment to Register Highest CAGR in Point of Care/ Rapid Diagnostics Market During Forecast Period 10.3 OTC Testing Products 10.3.1 OTC Testing Products market, 2020 - 2028 (USD Million) Figure 49: OTC Testing Products market, 2020 - 2028 (USD Million) 10.4 Prescription-based Testing Products 10.4.1 Prescription-based Testing Products market, 2020 - 2028 (USD Million) Figure 50: Prescription-based Testing Products market, 2020 - 2028 (USD Million) Chapter 11. Global Point of Care/ Rapid Diagnostics Market: Platform Segment Analysis 11.1 Introduction 11.2 Sales Volume & Revenue Analysis (2020-2028) Table 12 Point of Care/ Rapid Diagnostics Market, By Platform, 2021–2028 (USD Million) Figure 51 Point of Care/ Rapid Diagnostics Market, By Platform Figure 52 Lateral Flow Assays Segment to Register Highest CAGR in Point of Care/ Rapid Diagnostics Market During Forecast Period 11.3 Lateral Flow Assays 11.3.1 Lateral Flow Assays market, 2020 - 2028 (USD Million) Figure 53: Lateral Flow Assays market, 2020 - 2028 (USD Million) 11.4 Immunoassays 11.4.1 Immunoassays market, 2020 - 2028 (USD Million) Figure 54: Immunoassays market, 2020 - 2028 (USD Million) 11.4 Microfluidics 11.4.1 Microfluidics market, 2020 - 2028 (USD Million) Figure 55: Microfluidics market, 2020 - 2028 (USD Million) 11.4 Molecular Diagnostics 11.4.1 Molecular Diagnostics market, 2020 - 2028 (USD Million) Figure 56: Molecular Diagnostics market, 2020 - 2028 (USD Million) 11.4 Dipsticks 11.4.1 Dipsticks market, 2020 - 2028 (USD Million) Figure 57: Dipsticks market, 2020 - 2028 (USD Million) Chapter 12. Global Point of Care/ Rapid Diagnostics Market: Regional Outlook 12.1 North America Figure 58: North America Point of Care/ Rapid Diagnostics Market, By Revenue Forecast (2020-2028) 12.1.1 North America Point of Care/ Rapid Diagnostics market, by country, 2020 - 2028 (USD Million) Table 13: North America Point of Care/ Rapid Diagnostics Market, by Country, 2020-2028 Figure 59: North America Point of Care/ Rapid Diagnostics Market 12.1.2 North America Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Table14: North America Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 60: North America Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.1.3 North America Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Table 15: North America Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 61: North America Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.1.4 U.S. 13.1.4.1 U.S. Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 62: U.S. Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.1.4.2 U.S. Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 63: U.S. Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.1.5 Canada 12.1.5.1 Canada Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 64: Canada Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.1.5.2 Canada Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 65: Canada Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 66: Canada Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 67: Canada Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.2 Europe Figure 68: Europe Point of Care/ Rapid Diagnostics Market, By Revenue Forecast (2020-2028) 12.2.1 Europe Point of Care/ Rapid Diagnostics market, by country, 2020 - 2028 (USD Million) Table 16: Europe Point of Care/ Rapid Diagnostics market, by country, 2020 - 2028 (USD Million) Figure 69: Europe Point of Care/ Rapid Diagnostics market, by country, 2020 - 2028 (USD Million) 12.2.2 Europe Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Table 17: Europe Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 70: Europe Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.2.3 Europe Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Table 18: Europe Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 71: Europe Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.2.4 U.K. 12.2.4.1 U.K. Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 72: U.K. Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.2.4.2 U.K. Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 73: U.K. Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.2.5 Germany 12.2.5.1 Germany Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 74: Germany Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.2.5.2 Germany Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 75: Germany Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.2.6 France 13.2.6.1 France Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 76: France Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.2.6.2 France Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 77: France Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.2.7 Rest of Europe 12.2.7.1 Rest of Europe Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 78: Rest of Europe Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.2.7.2 Rest of Europe Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 79: Rest of Europe Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.3 Asia Pacific Figure 80: Asia Pacific Point of Care/ Rapid Diagnostics Market, By Revenue Forecast (2020-2028) 12.3.1 Asia Pacific Point of Care/ Rapid Diagnostics market, by country, 2020 - 2028 (USD Million) Table 29: Asia Pacific Point of Care/ Rapid Diagnostics market, by country, 2020 - 2028 (USD Million) Figure 81: Asia Pacific Point of Care/ Rapid Diagnostics market, by country, 2020 - 2028 (USD Million) 12.3.2 Asia Pacific Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Table 20: Asia Pacific Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 82: Asia Pacific Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.3.3 Asia Pacific Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Table 21: Asia Pacific Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 83: Asia Pacific Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.3.4 China 10.3.4.1 China Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 84: China Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 13.3.4.2 China Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 85: China Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.3.5 India 12.3.5.1 India Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 86: India Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.3.5.2 India Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 87: India Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.3.6 Japan 12.3.6.1 Japan Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 88: Japan Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.3.6.2 Japan Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 89: Japan Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.3.7 South Korea 12.3.7.1 South Korea Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 90: South Korea Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.3.7.2 South Korea Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 91: South Korea Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.3.8 Rest of APAC 12.3.8.1 Rest of APAC Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 92: Rest of APAC Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.3.8.2 Rest of APAC Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 93: Rest of APAC Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.4 Latin America Figure 94: Latin America Point of Care/ Rapid Diagnostics Market, By Revenue Forecast (2020-2028) 12.4.1 Latin America Point of Care/ Rapid Diagnostics market, by country, 2020 - 2028 (USD Million) Table 22: Latin America Point of Care/ Rapid Diagnostics market, by country, 2020 - 2028 (USD Million) Figure 95: Latin America Point of Care/ Rapid Diagnostics market, by country, 2020 - 2028 (USD Million) 12.4.2 Latin America Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Table 23: Latin America Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 96: Latin America Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.4.3 Latin America Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Table 24: Latin America Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 97: Latin America Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.4.4 Brazil 12.4.4.1 Brazil Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 98: Brazil Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.4.4.2 Brazil Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 99: Brazil Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.4.5 Mexico 12.4.5.1 Mexico Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 100: Mexico Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.4.5 2 Mexico Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 101: Mexico Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.4.6 Rest of the Latin America 12.4.6.1 Rest of the Latin America Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 102: Rest of the Latin America Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.4.6.2 Rest of the Latin America Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 103: Rest of the Latin America Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) 12.5 MEA Figure 104: MEA Point of Care/ Rapid Diagnostics Market, By Revenue Forecast (2020-2028) 12.5.1 MEA Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) Figure 105: MEA Point of Care/ Rapid Diagnostics market, by Product, 2020 - 2028 (USD Million) 12.5.2 MEA Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Figure 106: MEA Point of Care/ Rapid Diagnostics market, by End-User, 2020 - 2028 (USD Million) Chapter 13. Competitive Landscape 13.1 Roche Diagnostics. 13.1.1 Company overview 13.1.2 Financial performance 13.1.3 Product Portfolio Analysis 13.1.4 Business Strategy & Recent Development 13.2 Siemens Healthineers. 13.2 .1 Company overview 13.2 .2 Financial performance 13.2 .3 Product Portfolio Analysis 13.2 .4 Business Strategy & Recent Development 13.3 Abbott Laboratories. 13.3.1 Company overview 13.3.2 Financial performance 13.3.3 Product Portfolio Analysis 13.3.4 Business Strategy & Recent Development 13.4 Danaher Corporation. 13.4.1 Company overview 13.4.2 Financial performance 13.4.3 Product Portfolio Analysis 13.4.4 Business Strategy & Recent Development 13.5 Becton Dickinson and Company. 13.5.1 Company overview 13.5.2 Financial performance 13.5.3 Product Portfolio Analysis 13.5.4 Business Strategy & Recent Development 13.6 Chembio Diagnostics. 13.6.1 Company overview 13.6.2 Financial performance 13.6.3 Product Portfolio Analysis 13.6.4 Business Strategy & Recent Development 13.7 Quidel Diagnostics. 13.7.1 Company overview 13.7.2 Financial performance 13.7.3 Product Portfolio Analysis 13.7.4 Business Strategy & Recent Development 13.8 EKF Diagnostics. 13.8.1 Company overview 13.8.2 Financial performance 13.8.3 Product Portfolio Analysis 13.8.4 Business Strategy & Recent Development 13.9 Trinity Biotech. 13.9.1 Company overview 13.9.2 Financial performance 13.9.3 Product Portfolio Analysis 13.9.4 Business Strategy & Recent Development 13.10 Fluxergy. 13.10.1 Company overview 13.10.2 Financial performance 13.10.3 Product Portfolio Analysis 13.10.4 Business Strategy & Recent Development